Health Care & Life Sciences » Pharmaceuticals | KYORIN Holdings Inc.

KYORIN Holdings Inc. | Cash Flow

Fiscal year is April-March. All values JPY Millions.
2014
2015
2016
2017
2018
2019
Net Income before Extraordinaries
18,312
17,561
18,815
9,716
9,061
9,359
Depreciation, Depletion & Amortization
3,217
3,053
3,730
3,619
3,644
2,940
Other Funds
5,503
7,196
3,292
3,653
2,201
3,181
Funds from Operations
16,026
13,418
19,253
9,682
10,504
9,118
Changes in Working Capital
3,267
7,027
8,116
6,704
48
8,778
Net Operating Cash Flow
19,293
6,391
11,137
16,386
10,456
340
Capital Expenditures
3,095
5,855
7,342
2,645
3,873
Sale of Fixed Assets & Businesses
415
4,756
2,066
89
525
Purchase/Sale of Investments
41
55
6,129
10,561
2,145
Net Investing Cash Flow
2,477
1,364
650
13,142
6,038
Cash Dividends Paid - Total
3,736
4,626
3,876
4,322
4,325
Issuance/Reduction of Debt, Net
33
1,579
2,089
953
66
Net Financing Cash Flow
3,704
5,233
2,245
5,721
3,735
Net Change in Cash
13,285
100
9,315
2,542
473
Free Cash Flow
16,671
1,008
4,325
14,178
7,069
Net Assets from Acquisitions
-
-
-
-
399
Other Sources
162
-
-
-
-
Change in Capital Stock
1
2,186
458
445
524
Exchange Rate Effect
173
106
227
65
210
Other Uses
-
320
203
26
146

About KYORIN Holdings

View Profile
Address
Ochanomizu Sola City, 16/F
Tokyo Tokyo 101
Japan
Employees -
Website http://www.kyorin-gr.co.jp
Updated 07/08/2019
KYORIN Holdings, Inc. engages in the development, manufacture and sale of pharmaceutical products through its subsidiaries. It operates through the following segments: Pharmaceutical Business and Healthcare Business. The Pharmaceutical Business segment engages in the production and sales of prescription drugs, generic drugs, and over the counter drugs.